Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2
Ziqian Wang,Ting Song,Zongwei Guo,Keke Cao,Chao Chen,Yingang Feng,Hang Wang,Fangkui Yin,Sheng Zhou,Jian Dai,Zhichao Zhang
DOI: https://doi.org/10.1021/acs.jmedchem.0c01290
IF: 8.039
2020-11-16
Journal of Medicinal Chemistry
Abstract:Protein phosphorylation is the most significant post-translational modification for regulating cellular activities, but site-specific modulation of phosphorylation is still challenging. Using three-dimensional NMR spectra, molecular dynamics simulations, and alanine mutations, we identified that the interaction network between pT69/pS70 and R106/R109 residues prevents the phosphorylation sites from exposure to phosphatase and subsequent dephosphorylation. A Bcl-2-dephosphorylation probe, <b>S1-6e</b>, was designed by installing a carboxylic acid group to a Bcl-2 inhibitor. The carboxyl group competitively disrupts the interaction network between R106/R109 and pT69/pS70 and subsequently facilitates Bcl-2 dephosphorylation in living cells. As a result, <b>S1-6e</b> manifests a more effective apoptosis induction in pBcl-2-dependent cancer cells than other inhibitors exhibiting a similar binding affinity for Bcl-2. We believe that targeting the allosteric pathways interconnecting the core-functional domain and the phosphorylation site can be a general strategy for a rational design of site-specific dephosphorylating probes, since the allosteric pathway has been discovered in a variety of proteins.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01290?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01290</a>.List of (φ, ψ) backbone angle pairs for residues R106-D111, diagram of the phosphorylation sites of Bcl-2, 3D NMR titration spectra of different Bcl-2 variants, crystal structure of Bcl-2 isoform 2 in complex with ABT-263 or ABT-199 analogue, plot of the RMSD values of the backbone atoms in MD, binding affinity curves of BH3 peptides or compounds with different Bcl-2 variants, binding affinity curves of compounds with Bcl-xl and Mcl-1, and LC–MS spectra of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_001.pdf">PDF</a>)MD-simulated structure of pBcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_002.pdb">PDB</a>)Docking-stimulated structure of <b>S1-6e</b>/Bcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_003.pdb">PDB</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_004.csv">CSV</a>)This article has not yet been cited by other publications.
chemistry, medicinal